Evidence map›Paper›PMID 39060258›Full record

ArticleNature communications2024

Cholesterol-rich lysosomes induced by respiratory syncytial virus promote viral replication by blocking autophagy flux.

Lifeng Chen, Jingjing Zhang, Weibin Xu, Jiayi Chen, Yujun Tang, Si Xiong, Yaolan Li, Hong Zhang, Manmei Li, Zhong Liu

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Exploring CCND1 as a Key Target ofCurrent issues in molecular biology · 2025
    Article
  13. Review
  14. Review
  15. Slimformer: An NLP-based web server for semantic categorization of gene sets.Computational and structural biotechnology journal · 2025
    Article
  16. Review
  17. Virus infection and vesicle trafficking.Frontiers in immunology · 2025
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lifeng Chen *State Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China.ORCID 0009-0008-0002-6127
Jingjing Zhang *State Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China.ORCID 0009-0007-1668-7141
Weibin Xu *State Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China.ORCID 0009-0003-5590-3549
Jiayi ChenState Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China.ORCID 0009-0009-5127-227X
Yujun TangState Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China.ORCID 0009-0009-6646-088X
Si XiongState Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China.ORCID 0009-0000-8979-991X
Yaolan LiState Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China.ORCID 0000-0001-5045-5749
Hong ZhangDepartment of Dermatology, The First Affiliated Hospital, Jinan University, Guangzhou, China. tzhangh@jnu.edu.cn.ORCID 0000-0002-5063-4082
Manmei LiState Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China. jnulimanmei1209@126.com.ORCID 0000-0003-2423-3119
Zhong LiuState Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China. tliuzh@jnu.edu.cn.ORCID 0000-0002-5132-7463

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82073895National Natural Science Foundation of China (National Science Foundation of China) 82204464National Natural Science Foundation of China (National Science Foundation of China) 82273979National Natural Science Foundation of China (National Science Foundation of China) 82274180
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) hijacks cholesterol or autophagy pathways to facilitate optimal replication. However, our understanding of the associated molecular mechanisms remains limited. Here, we show that RSV infection blocks cholesterol transport from lysosomes to the endoplasmic reticulum by downregulating the activity of lysosomal acid lipase, activates the SREBP2-LDLR axis, and promotes uptake and accumulation of exogenous cholesterol in lysosomes. High cholesterol levels impair the VAP-A-binding activity of ORP1L and promote the recruitment of dynein-dynactin, PLEKHM1, or HOPS VPS39 to Rab7-RILP, thereby facilitating minus-end transport of autophagosomes and autolysosome formation. Acidification inhibition and dysfunction of cholesterol-rich lysosomes impair autophagy flux by inhibiting autolysosome degradation, which promotes the accumulation of RSV fusion protein. RSV-F storage is nearly abolished after cholesterol depletion or knockdown of LDLR. Most importantly, the knockout of LDLR effectively inhibits RSV infection in vivo. These findings elucidate the molecular mechanism of how RSV co-regulates lysosomal cholesterol reprogramming and autophagy and reveal LDLR as a novel target for anti-RSV drug development.

Indexed as

AutophagyCholesterolLysosomesrab7 GTP-Binding Proteinsrab GTP-Binding ProteinsReceptors, LDLRespiratory Syncytial Virus InfectionsVesicular Transport ProteinsVirus ReplicationA549 CellsAdaptor Proteins, Signal TransducingAnimalsAutophagosomesDynactin ComplexDyneinsEndoplasmic ReticulumAdaptor Proteins, Signal TransducingCholesterolDynactin ComplexDyneinsLDLR protein, humanrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, humanrab GTP-Binding ProteinsReceptors, LDLRILP protein, humanVAPA protein, humanVesicular Transport ProteinsViral Fusion Proteins

Identifiers

PMID39060258
PMCPMC11282085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.